Last month CanTeen became the latest organisation to join the CT:IQ Steering Committee. Bringing an important perspective, CanTeen help young people cope with cancer in their family and provide specialist youth-specific treatment teams and have young people affected by cancer guiding the organisation at every level. CanTeen are one of the many organisations that have demonstrated their support of the CT:IQ initiative by joining the Steering Committee. Others include the Icon Cancer Foundation, Novartis, SPHERE, Cancer Trials Australia, Neuroscience Trials Australia, Linear and CMAX.

In June Medicines Australia also announced that they were joining the executive committee. For further information about the CT:IQ initiative please visit their website at https://ctiq.com.au or if you are interested in joining please visit https://ctiq.com.au/contact-us